SynthesisFrontiers in immunology2026

Platelet-to-lymphocyte ratio for prognostication in immune checkpoint inhibitor-treated cancer patients: a meta-analysis of 13027 patients highlighting nivolumab-responsive renal cell carcinoma.

Mingxing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.